Ligand(LGND) - 2024 Q1 - Earnings Call Transcript
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q1 2024 Earnings Conference Call May 7, 2024 4:30 PM ET Company Participants Michael Jeong - Investor Relations Todd Davis - Chief Executive Officer Paul Hadden - Senior Vice President, Investments & Business Development Karen Reeves - Senior Vice President-Clinical Strategy & Investments Matt Korenberg - President & Chief Operating Officer Tavo Espinoza - Chief Financial Officer Conference Call Participants Matt Hewitt - Craig-Hallum Capital Group Joe Pantg ...